StockSelector.com
  Research, Select, & Monitor Saturday, September 22, 2018 9:27:59 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Cara Therapeutics Inc.$23.18($.74)(3.09%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Cara Therapeutics Inc. has an overall rank of 4045 out of 7243 stocks based on 8 positive rankings and 8 negative rankings.

Positive Rankings
Estimated Revenue Growth
Cara Therapeutics Inc. rank is 25
90 Day Gain
Cara Therapeutics Inc. rank is 136
Low vPut/Call
Cara Therapeutics Inc. has a low Put/Call ratio of 0.07 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cara Therapeutics Inc. is ranked 184.
Debt-to-Equity
Cara Therapeutics Inc. rank is 224
10 Day Gain
Cara Therapeutics Inc. rank is 272
Low Put/Call
Cara Therapeutics Inc. has a low Put/Call ratio of 0.11 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cara Therapeutics Inc. is ranked 280.
Highest Cash Growth
Cara Therapeutics Inc. rank is 357
Target Prices
The average analysts' target price is $27.33 for Cara Therapeutics Inc. using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Cara Therapeutics Inc. is ranked 405.
Negative Rankings
Price-to-Sales
Cara Therapeutics Inc. rank is 65
Negative Stoch Cross
Cara Therapeutics Inc. rank is 72
Negative Net Margin
Cara Therapeutics Inc. rank is 118
Down EPS Surprise
Cara Therapeutics Inc. missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROA
Cara Therapeutics Inc. rank is 452
Negative ROE
Cara Therapeutics Inc. rank is 490
Price-to-Book
Cara Therapeutics Inc. rank is 562
Negative Revenue Growth
Cara Therapeutics Inc. rank is 703







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.